Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Citi
Baxter
AstraZeneca
Teva

Generated: April 22, 2019

DrugPatentWatch Database Preview

Bluepharma Company Profile

« Back to Dashboard

What is the competitive landscape for BLUEPHARMA, and what generic and branded alternatives to BLUEPHARMA drugs are available?

BLUEPHARMA has four approved drugs.



Summary for Bluepharma
US Patents:0
Tradenames:4
Ingredients:3
NDAs:4

Drugs and US Patents for Bluepharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bluepharma GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078863-001 Jun 30, 2008 AP RX No No ➤ Sign Up ➤ Sign Up
Bluepharma GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE granisetron hydrochloride INJECTABLE;INJECTION 078863-002 Jun 30, 2008 AP RX No No ➤ Sign Up ➤ Sign Up
Bluepharma ANESTACON lidocaine hydrochloride JELLY;TOPICAL 080429-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bluepharma ZONISAMIDE zonisamide CAPSULE;ORAL 077813-002 Aug 16, 2006 AB RX No No ➤ Sign Up ➤ Sign Up
Bluepharma ZONISAMIDE zonisamide CAPSULE;ORAL 077813-003 Aug 16, 2006 AB RX No No ➤ Sign Up ➤ Sign Up
Bluepharma GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078880-001 Jun 30, 2008 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKinsey
Federal Trade Commission
Daiichi Sankyo
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.